Join to view full profile
525 E 68th St"# M-528"New York, NY 10065
Phone+1 212-746-4749
Fax+1 212-746-6692
Join Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Jagan Muppidi, MD is an oncologist in New York, New York. He is currently licensed to practice medicine in California.
Education & Training
University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 2009 - 2011
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2006 - 2009
University of Kansas School of MedicineClass of 2006
Certifications & Licensure
CA State Medical License 2009 - 2027
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory EHR Suite, Epic Systems Corporation, 2014-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2014-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014-2017
Publications & Presentations
PubMed
- 4 citationsPhosphatidylserine phospholipase A1 enables GPR34-dependent immune cell accumulation in the peritoneal cavity.Hanson Tam, Ying Xu, Jinping An, Torsten Schöneberg, Angela Schulz
The Journal of Experimental Medicine. 2024-11-04 - 12 citationsMolecular Determinants of Sensitivity to Polatuzumab Vedotin in Diffuse Large B-Cell Lymphoma.Sean R Corcoran, James D Phelan, Jaewoo Choi, Galina Shevchenko, Rachel E Fenner
Cancer Discovery. 2024-09-04 - 2 citationsGα13 restricts nutrient driven proliferation in mucosal germinal centers.Hang T Nguyen, Moyi Li, Rahul Vadakath, Keirstin A Henke, Tam C Tran
Nature Immunology. 2024-09-01
Grant Support
- The role of Galpha13 signaling in suppression of lymphomaDIVISION OF BASIC SCIENCES - NCIPresent










